Volume 12, Issue 2 (Summer 2015)                   Sci J Iran Blood Transfus Organ 2015, 12(2): 143-152 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Beiki B, Zarrabi M, Radmanesh M. A rapid, simple and economical method for the isolationof mesenchymal stem cells from Wharton’s jellyby phosphate buffer saline. Sci J Iran Blood Transfus Organ 2015; 12 (2) :143-152
URL: http://bloodjournal.ir/article-1-863-en.html
A rapid, simple and economical method for the isolationof mesenchymal stem cells from Wharton’s jellyby phosphate buffer saline
B. Beiki * , M. Zarrabi , M. Radmanesh
Keywords: Key words : Mesenchymal Stem Cells, umbilicla cord, Wharton Jelly
Full-Text [PDF 749 kb]   (1846 Downloads)     |   Abstract (HTML)  (6548 Views)
Full-Text:   (4704 Views)
References :  
  1. Sensebe´ L, Bourin P. Mesenchymal stem cells for  therapeutic purposes. Transplantation  2009; 87(9 Suppl): S49-53.
  2. Bajada S, Mazakova I, Richardson JB, Ashammakhi N. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008; 2(4): 169-83.
  3. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007; 25(11): 2886-95.
  4. Troyer DL, Weiss ML. Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells 2008; 26(3): 591-9.
  5. Wang XY, Lan Y, He WY, Zhang L, Yao HY, Hou CM, Tong Y, et al. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. Blood 2008; 111(4): 2436-43.
  6. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21(1): 105-10.
  7. Carlin R, Davis D, Weiss M, Schultz B, Troyer D. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 2006; 4: 8.
  8. McElreavey KD, Irvine AI, Ennis KT, McLean WH. Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton’s jelly portion of human umbilical cord. Biochem Soc Trans 1991; 19(1): 29S.
  9. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, et al. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 2004; 22(7): 1330-7.
  10. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007; 25(2): 319-31.
  11. Pereira WC, Khushnooma I, Madkaikar M, Ghosh K. Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. J Tissue Eng Regen Med 2008; 2(7): 394-9.
  12. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23(2): 220-9.
  13. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W,
 
 
et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006; 91(8): 1017-26.
  1. Kadam SS, Tiwari S, Bhonde RR. Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. In Vitro Cell Dev Biol Anim 2009; 45(1-2): 23-7.
  2. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, et al. Isolation and characterization of Oct-4‏=HLA-G‏ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers.  Histochem Cell Biol 2009; 131(2): 267-82.
  3. Valencic E, Piscianz E, Andolina M, Ventura A and Tommasini A. The immunosuppressive effect of Wharton’s jelly stromal cells depends on the timing of their licensing and on lymphocyte activation.  Cytotherapy 2010; 12(2): 154-60.
  4. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, et al. Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells 2008; 26(11): 2865-74.
  5. Zeddou M, Briquet A, Relic B, Josse C, Malaise MG, Gothot A, et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC)  than the umbilical cord blood. Cell Biol Int 2010; 34(7): 693-701.
  6. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carvalho MD, et al. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 2008; 26(1): 146-50.
  7. Hung CT, Mauck RL. Biological Assays: Cellular Level. In: Moore J, Zouridakis G. Biomedical Technology and Devices Handbook. Boca Raton, FL: CRC Press; 2004. p. 1-15, 39.
  8. Ishige I, Nagamura-Inoue T, Honda MJ, Harnprasopwat R, Kido M, Sugimoto M, et al. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord. Int J Hematol 2009; 90(2): 261-9.
  9. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, et al. Matrix cells from Wharton’s jelly form neurons and glia. Stem Cells 2003; 21(1): 50-60.
  10. Penolazzi L, Vecchiatini R, Bignardi S, Lambertini E, Torreggiani E, Canella A, et al. Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells. Reprod Biol Endocrinol 2009; 7: 106.   
 
 
 
 
 
 
 
 
Sci J Iran Blood Transfus Organ 2015; 12(2): 143-152
 
Original  Article
 
 
 

 

A rapid, simple and economical method for the isolation
of mesenchymal stem cells from Wharton’s jelly
by phosphate buffer saline
 
Beiki B.1, Zarrabi M.1, Radmanesh M.1
 
 
 
 1Cord Blood Bank, Royan Stem Cell Technology, Tehran, Iran
 
 
Abstract
Background and Objectives
The isolation of mesenchymal stem cells (MSCs) from the Wharton jelly (WJ) without degradation of cellular surface receptors and with the protection of cellular function, proliferation,  and viability is important for research and clinical applications. In this study we have established a simple and rapid protocol without enzymatic treatment taking less time for MSCs from WJ to be isolated.
 
Materials and Methods
Human umbilical cords were collected after full-term deliveries and transported to the laboratory in sterile phosphate-buffered saline (PBS).  After the removal of cords vessels, the WJ sectioned were transferred into PBS and put on a shaker for 2 hours. The cord segments were discarded and the suspension was centrifuged and cultured in DMEM-LG supplemented with 10% FBS for 5 days. The plastic adherent cells were investigated for surface markers. Adipogenic, osteogenic, and chondrogenic differentiations were performed to investigate the mesenchymal nature.
 
Results
After 5 days, purified populations of spindle-shape mesenchymal stem cell appeared and the cells were then expanded until they reached subconfluence. The cell population doubling time at third (31 ± 6h) and fourth (58 ± 15h ) passages was lower than other passages.  The expanded cells were positive for CD 90, CD105, CD73, and CD44 , and negative for CD34/45, CD133, and HLA-DR surface markers. WJ-MSCs showed the potential of the multilineage cell differentiation into adipogenic, osteogenic, and chondrogenic phenotypes.
 
Conclusions
This study indicates that this non-enzymatic protocol can result in the efficient isolation of MSCs from Wharton jelly with less time taken. The expanded cells expressed characteristic markers and presented typical functional properties of MSCs such as the differentiation capacities. 
 
Key words: Mesenchymal Stem Cells, umbilicla cord, Wharton Jelly
 
 
 
Received:  21 May 2014
Accepted: 26 Nov 2014
 
 

 

Correspondence: Beiki B., PhD of Developmental Biology. Cord Blood Bank, Royan Stem Cell Technology.
P.O.Box: 16656-66311, Tehran, Iran. Tel: (+9821) 22514052; Fax: (+9821) 89781308
E-mail: bahar_beigy58715@yahoo.com
Type of Study: Research | Subject: Stem cells
Published: 2015/07/5
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb